126 related articles for article (PubMed ID: 15372500)
1. Fate of transient catecholaminergic cell types revealed by site-specific recombination in transgenic mice.
Matsushita N; Kobayashi K; Miyazaki J; Kobayashi K
J Neurosci Res; 2004 Oct; 78(1):7-15. PubMed ID: 15372500
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
[TBL] [Abstract][Full Text] [Related]
3. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
Hayashi S; McMahon AP
Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
[TBL] [Abstract][Full Text] [Related]
5. Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT.
Stubbusch J; Majdazari A; Schmidt M; Schütz G; Deller T; Rohrer H
Genesis; 2011 Dec; 49(12):935-41. PubMed ID: 21634003
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system.
Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H
Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724
[TBL] [Abstract][Full Text] [Related]
7. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression.
Score PR; Belur LR; Frandsen JL; Geurts JL; Yamaguchi T; Somia NV; Hackett PB; Largaespada DA; McIvor RS
Mol Ther; 2006 Mar; 13(3):617-24. PubMed ID: 16356773
[TBL] [Abstract][Full Text] [Related]
8. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping of sensory and sympathetic ganglion neurons of a galanin-overexpressing mouse--possible implications for pain processing.
Brumovsky P; Hygge-Blakeman K; Villar MJ; Watanabe M; Wiesenfeld-Hallin Z; Hökfelt T
J Chem Neuroanat; 2006 Jun; 31(4):243-62. PubMed ID: 16546349
[TBL] [Abstract][Full Text] [Related]
10. Neural expression of alpha-internexin promoter in vitro and in vivo.
Wang P; Wang SM; Hsieh CJ; Chien CL
J Cell Biochem; 2006 Feb; 97(2):275-87. PubMed ID: 16173078
[TBL] [Abstract][Full Text] [Related]
11. Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia.
Agarwal N; Offermanns S; Kuner R
Genesis; 2004 Mar; 38(3):122-9. PubMed ID: 15048809
[TBL] [Abstract][Full Text] [Related]
12. Cre-loxP mediated control of PrP to study transmissible spongiform encephalopathy diseases.
Tuzi NL; Clarke AR; Bradford B; Aitchison L; Thomson V; Manson JC
Genesis; 2004 Sep; 40(1):1-6. PubMed ID: 15354287
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus.
Lindeberg J; Usoskin D; Bengtsson H; Gustafsson A; Kylberg A; Söderström S; Ebendal T
Genesis; 2004 Oct; 40(2):67-73. PubMed ID: 15452869
[TBL] [Abstract][Full Text] [Related]
14. A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons.
Kido T; Lau YF
Genesis; 2005 Aug; 42(4):263-75. PubMed ID: 16035036
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
[TBL] [Abstract][Full Text] [Related]
16. Novel pan-neuronal Cre-transgenic line for conditional ablation of genes in the nervous system.
Banares S; Zeh K; Krajewska M; Kermer P; Baribault H; Reed JC; Krajewski S
Genesis; 2005 May; 42(1):6-16. PubMed ID: 15828007
[TBL] [Abstract][Full Text] [Related]
17. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
[TBL] [Abstract][Full Text] [Related]
18. A novel technique for temporally regulated cell type-specific Cre expression and recombination in the pituitary gonadotroph.
Naik K; Pittman I; Wolfe A; Miller RS; Radovick S; Wondisford FE
J Mol Endocrinol; 2006 Aug; 37(1):63-9. PubMed ID: 16901924
[TBL] [Abstract][Full Text] [Related]
19. Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system.
Bradley CK; Takano EA; Göthert JR; Göttgens B; Green AR; Begley CG; van Eekelen JA
Genesis; 2007 Mar; 45(3):145-51. PubMed ID: 17330263
[TBL] [Abstract][Full Text] [Related]
20. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
